PMID- 37324626
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230619
IS  - 2297-055X (Print)
IS  - 2297-055X (Electronic)
IS  - 2297-055X (Linking)
VI  - 10
DP  - 2023
TI  - Robotic-assisted mitral valve surgery without aortic cross-clamping: a safe and 
      feasible technique.
PG  - 1111496
LID - 10.3389/fcvm.2023.1111496 [doi]
LID - 1111496
AB  - BACKGROUND: The primary objective of this study was to evaluate the safety and 
      feasibility of robotic-assisted mitral valve surgery without aortic 
      cross-clamping. METHODS: From January 2010 to September 2022, 28 patients 
      underwent robotic-assisted mitral valve surgery without aortic cross-clamping in 
      our center using DaVinci Robotic Systems. Clinical data during the perioperative 
      period and early outcomes of the patients were recorded. RESULTS: Most patients 
      were in New York Heart Association (NYHA) class II and III. Mean age and 
      EuroScore II of the patients were 71.5 +/- 13.5 and 8.4 +/- 3.7 respectively. The 
      patients underwent either mitral valve replacement (n = 16, 57.1%) or mitral 
      valve repair (n = 12, 42.9%). Concomitant procedures were performed including 
      tricuspid valve repair, tricuspid valve replacement, PFO closure, left atrial 
      appendage ligation, left atrial appendage thrombectomy and cryoablation for 
      atrial fibrillation. Mean CPB times were 140.9 +/- 44.6 and mean fibrillatory 
      arrest duration was 76.6 +/- 18.4. Mean duration of ICU stay was 32.5 +/- 28.8 h and 
      mean duration of hospital stay 9.8 +/- 8.3 days. One patient (3.6%) underwent 
      revision due to bleeding. New onset renal failure was observed in one (3.6%) 
      patient and postoperative stroke in one (3.6%) patient. Postoperative early 
      mortality was observed in two (7.1%) patients. CONCLUSIONS: Robotic-assisted 
      mitral valve surgery without cross-clamping is a safe and feasible technique in 
      high-risk patients undergoing redo mitral surgery with severe adhesions as well 
      as in primary mitral valve cases that are complicated with ascending aortic 
      calcification.
CI  - (c) 2023 Okten, Ozcan, Arslanhan, Senay, Gullu, Kocyigit, Degirmencioglu and Alhan.
FAU - Okten, Eyup Murat
AU  - Okten EM
AD  - Department of Cardiovascular Surgery, Acibadem Mehmet Ali Aydinlar University 
      School of Medicine, Istanbul, Turkiye.
FAU - Ozcan, Zeynep Sila
AU  - Ozcan ZS
AD  - Department of Cardiovascular Surgery, Acibadem Mehmet Ali Aydinlar University 
      School of Medicine, Istanbul, Turkiye.
FAU - Arslanhan, Gokhan
AU  - Arslanhan G
AD  - Department of Cardiovascular Surgery, Acibadem Maslak Hospital, Istanbul, 
      Turkiye.
FAU - Senay, Sahin
AU  - Senay S
AD  - Department of Cardiovascular Surgery, Acibadem Mehmet Ali Aydinlar University 
      School of Medicine, Istanbul, Turkiye.
FAU - Gullu, Ahmet Umit
AU  - Gullu AU
AD  - Department of Cardiovascular Surgery, Acibadem Mehmet Ali Aydinlar University 
      School of Medicine, Istanbul, Turkiye.
FAU - Kocyigit, Muharrem
AU  - Kocyigit M
AD  - Department of Anesthesiology, Acibadem Mehmet Ali Aydinlar University School of 
      Medicine, Istanbul, Turkiye.
FAU - Degirmencioglu, Aleks
AU  - Degirmencioglu A
AD  - Department of Cardiology, Acibadem Mehmet Ali Aydinlar University School of 
      Medicine, Istanbul, Turkiye.
FAU - Alhan, Cem
AU  - Alhan C
AD  - Department of Cardiovascular Surgery, Acibadem Mehmet Ali Aydinlar University 
      School of Medicine, Istanbul, Turkiye.
LA  - eng
PT  - Journal Article
DEP - 20230530
PL  - Switzerland
TA  - Front Cardiovasc Med
JT  - Frontiers in cardiovascular medicine
JID - 101653388
PMC - PMC10264847
OTO - NOTNLM
OT  - aortic cross-clamping
OT  - fibrillating heart
OT  - mitral surgery
OT  - mitral valve
OT  - robotic surgery
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/06/16 06:42
MHDA- 2023/06/16 06:43
PMCR- 2023/01/01
CRDT- 2023/06/16 04:13
PHST- 2022/11/29 00:00 [received]
PHST- 2023/05/15 00:00 [accepted]
PHST- 2023/06/16 06:43 [medline]
PHST- 2023/06/16 06:42 [pubmed]
PHST- 2023/06/16 04:13 [entrez]
PHST- 2023/01/01 00:00 [pmc-release]
AID - 10.3389/fcvm.2023.1111496 [doi]
PST - epublish
SO  - Front Cardiovasc Med. 2023 May 30;10:1111496. doi: 10.3389/fcvm.2023.1111496. 
      eCollection 2023.